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Abstract 
Skin penetration enhancers are used to allow formulation of transdermal delivery 
systems for drugs that are otherwise insufficiently skin permeable. A full 
understanding of the mode of action could be beneficial for the design of potent 
enhancers and for the choice of the enhancer to be used in topical formulation of a 
special drug. In this study, the structural requirements of penetration enhancers have 
been investigated using the Quantitative Structure-Activity Relationship (QSAR) 
technique. Activities of naturally occurring terpenes, pyrrolidinone and N-
acetylprolinate derivatives on the skin penetration of 5-fluorouracil, diclofenac 
sodium, hydrocortisone, estradiol, and benazepril have been considered. The resulting 
QSARs indicated that for 5-fluorouracil and diclofenac sodium less hydrophobic 
enhancers were the most active. More precisely, molecular descriptors in the 
corresponding QSARs indicated the possible involvement of intermolecular electron 
donor-acceptor interactions. This was in contrast to the skin permeation promotion of 
hydrocortisone, estradiol, and benazepril by enhancers, where a linear relationship 
between enhancement activity and n-octanol/water partition coefficients of enhancers 
was evident. The possible mechanisms of penetration enhancement as suggested by 
the QSARs will be discussed. 
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1. Introduction 
 
The transdermal route offers several advantages over other routes for the delivery of 
drugs with systemic activity. These include the ease of use and withdrawal, in case of 
side effects, and avoidance of first-pass metabolism. However, skin is resistant to the 
permeation of most external chemicals and drugs. Physical and chemical methods 
have been implemented in order to increase absorption of drugs through skin [1]. The 
chemical methods involve incorporation of specific chemicals in topical drug 
formulations in order to increase the penetration of drug. The penetration enhancers 
facilitate the absorption of penetrant through the skin by temporarily increasing the 
permeability of the skin. Some of the important penetration enhancers as classified by 
Sinha and Kaur [2] are terpenes and terpenoids, pyrrolidinones, fatty acids and esters, 
sulfoxides, alcohols and glycerides, and miscellaneous enhancers including 
phospholipids, cyclodextrin complexes, amino acid derivatives, lipid synthesis 
inhibitors, clofibric acid, dodecyl-N,N-dimethylamino acetate, and enzymes. Because 
of their widely different chemical structures, it is likely that the enhancers act by more 
than one mechanism and that their precise enhancer activity will depend on the 
physicochemical properties of the penetrant as well as the enhancer [3]. Yu et al. [4], 
in a study of oleic acid-induced transdermal diffusion pathways, showed that the 
mechanism of oleic acid chemical enhancer action depends on the physicochemical 
properties of the model drug.  
The design of skin penetration enhancers would be facilitated by an understanding of 
their mode of action within the target tissue. Furthermore, it would be beneficial to the 
choice of the enhancer to be used in topical formulation of a certain drug, as the 
enhancing activities of enhancers towards different drugs are different. In this study, 
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the structural requirements for enhancement activities towards different drugs have 
been explored using the QSAR technique. Three chemical classes of enhancers, 
namely, terpenes, N-acetylprolinate esters and pyrrolidinone derivatives were 
investigated. Terpenes are naturally occurring volatile oils that appear to be promising 
candidates for use as clinically acceptable enhancers [5]. They have been reported to 
have good toxicological profiles, high percutaneous enhancement abilities, and low 
cutaneous irritancy at low concentrations [6]. Pyrrolidinones have recently become of 
interest to the pharmaceutical industry as penetration enhancers [7] and 2-
pyrrolidinone-5-carboxylic acid is a component of the natural moisturizing factors in 
the skin [8]. N-acetylprolinate esters have been synthesized by Tenjarla et al.. [9] and 
have been characterised as novel penetration enhancers. 
 
2. Material and Methods 
 
2.1 Transdermal penetration enhancement data 
The enhancers were selected on the basis that the number of enhancers whose 
activities towards a special drug have been measured under the same conditions was 
enough to construct a QSAR. The minimum number of observations (enhancers) for a 
single variable QSAR is five [10] but a higher number of chemicals will add to the 
robustness of the model. 
 
a) Terpene penetration enhancers: 
Figure 1 shows the molecular structure of the terpene enhancers used in this study. 
The enhancing activities of terpenes towards 5-fluorouracil, 5FU [11], hydrocortisone, 
HC [12], diclofenac sodium, DFS [13] and oestradiol [14] were used as the biological 
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response. Penetration-enhancing activities of terpenes were expressed as enhancement 
ratios (ER). The enhancement ratio for 5-FU and oestradiol is the permeability 
coefficient of the saturated solution of drug in water after terpene treatment 
(incubation with the pure terpene for 12 hours) divided by the permeability coefficient 
before terpene treatment through excised abdominal human skin [15]. The 
enhancement ratio for DFS and HC is the ratio of the permeability coefficient with 
enhancer to that obtained with control formulation without terpene. DFS was 
formulated as carbopol gel containing propylene glycol with the terpene concentration 
of 1% (w/w) and the penetration was measured in abdominal rat skin [13]. HC was 
formulated as HPMC gels containing ethanol, water and glycerol with 2% terpene 
[12] and hairless mouse skin was used as barrier. The enhancement ratios are listed in 
Table 1. In QSAR analyses throughout the paper logarithm of the ratio is used. 
 
[FIGURE 1 HERE] 
[TABLE 1 HERE] 
 
b) Pyrrolidinone derivatives 
The transdermal penetration-enhancing abilities of 16 pyrrolidinone derivatives 
(Figure 2) towards HC have been measured using hairless mouse skin in vitro. Skins 
were pretreated for 1 h with the enhancer in propylene glycol before application of the 
drug also in propylene glycol. Enhancement ratios have been reported for 
permeability coefficient (ER (kP)), and 24-h receptor concentration (ERQ24) [16]. The 
enhancement ratios are tabulated in Table 2. 
 
[FIGURE 2 HERE] 
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[TABLE 2 HERE] 
 
c) N-acetylprolinate esters 
The series consists of N-acetylprolinate esters with the alkyl side chain lengths of 5-
18 carbon atoms and Azone (Figure 3). The enhancement activities towards HC and 
benazepril have been measured in vitro using full thickness hairless mouse skin. 
Saturated drug solutions in propylene glycol with or without enhancers (5% (w/v)) 
have been used as the donor phase [9] and the enhancement ratios for permeability 
coefficients were reported (Table 3). 
 
[FIGURE 3 HERE] 
[TABLE 3 HERE] 
 
2.2. Structural descriptors 
The structures of the enhancers were generated and optimised using the COSMIC 
force field and the molecular mechanical descriptors were obtained using the 
NEMESIS software. The software was distributed by Oxford Molecular Ltd (Oxford, 
UK), Oxford Molecular was incorporated into Accelrys Inc. and the software 
packages are available through Accelrys Inc. The descriptors consisted of solvent 
accessible surface area, and the highest and the lowest electrostatic potential on the 
surface. The MNDO Hamiltonian in MOPAC 7.0 (QCPE, Department of Chemistry, 
Indiana University, 800 East Kirkwood Ave., Bloomington) was used for further 
minimisation of the structure and calculation of molecular orbital descriptors. These 
consisted of atomic charges, dipole moment, molecular weight, energies of the highest 
occupied and the lowest unoccupied molecular orbitals, as well as electrophilic and 
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nucleophilic superdelocalisability indices. Log P was calculated using the ACD / log 
D software (Advanced Chemistry Development Incorporated, Ontario, Canada). 
Molecular connectivity and molecular shape indices, as well as the atom level and 
bond electrotopological state indices were calculated by MOLCONN-Z software 
version 3.15 (Hall Associates, Quincy, MA). Molar volume, energy of vaporization 
and solubility parameter were calculated by a group contribution method [17].  
 
2.3. Development of QSARs 
Stepwise regression analysis was used to determine statistically significant 
relationships between structural parameters and the penetration enhancer activity. The 
statistical analyses were performed using the MINITAB statistical software (version 
13.1, MINITAB Inc.). In order to minimise the risk of chance correlations the 
maximum p-value for a descriptor to be included in equations was set at 0.10 and 
maximum number of descriptors in equations was lower than one fifth of the number 
of observations. Furthermore, the correlation between log ER and log P was explored 
by linear regression analysis and the resulting equation was reported for each dataset. 
The following statistical criteria of the models were noted: n the number of 
observations, r2 the squared of the correlation coefficient, s the standard deviation, F 
the Fisher statistic and the P value. 
 
3. Results 
 
3.1. Enhancement activity of terpenes towards 5FU 
Following equation was resulted for the 26 terpene enhancers: 
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Log ER = 0.138 (±0.26) - 5.79 (±0.95) q- - 0.46 (±0.13) EV/104 (1) 
N = 26       s = 0.329            r2 = 0.627         F = 19.3   P < 0.0005 
 
In equation 1, q- is the lowest atomic charge in the molecule and EV is the free energy 
of vaporisation. Although q- is an electrostatic parameter explaining electrostatic 
interactions, it has been shown that it can also model hydrogen bonding in QSAR 
equations, with ‘low’ q- values (high negative charges) leading to ‘high’ ability to 
accept hydrogens in hydrogen-bonding interactions [18, 19]. Therefore the negative 
slope of q- in equation 1 can indicate that increasing hydrogen-bonding-acceptor 
ability increases the enhancement ratio towards 5FU. The correlation with q- indicates 
that ketones, ethers and alcohols are better enhancers than are hydrocarbons. This can 
be shown by calculating the mean and standard deviation of ER values for alcohols, 
ethers, ketones and hydrocarbons as 0.97(±0.30), 1.24(±0.61), 1.18(±0.35) and 
0.29(±0.13), respectively. The equation also shows that terpenes with lower energies 
of vaporization are better penetration enhancers than are those possessing higher 
energies of vaporisation. Cyclic ethers and alcohols possess the lowest and the highest 
EV respectively. Thus a lower enhancement ratio for alcohols and the highest ER for 
cyclic ethers will be expected. This is evident in the scatter plot between the observed 
log ER and log ER calculated by equation 1 (Figure 4). Cyclohexene oxide is an 
outlier from equation 1 and its exclusion from regression analysis improves the 
correlation considerably (r2 = 0.762).  
 
[FIGURE 4 HERE] 
Linear regression between log ER and partition coefficient resulted in equation 2: 
Log ER5FU = 1.49 (±0.18) - 0.148 (±0.04) log P   (2) 
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n = 26    s = 0.428      r2 = 0.341     F = 12.4    P = 0.002 
 
Table 4 shows the equations obtained for the enhancement activities of different 
chemical groups. Note that the structural descriptors (selected by stepwise regression) 
in these equations are different. In other words different structural features are 
controlling the enhancement capabilities of each chemical class. In equations 3, SN= is 
the average of nucleophilic superdelocalisability indices for carbon atoms with double 
bonding. Nucleophilic superdelocalisability index for an atom is the sum of squares of 
the coefficients of atomic orbitals in each molecular orbital divided by the energy of 
that molecular orbital calculated for the unoccupied molecular orbitals [20]. The 
indices have been widely used in QSAR studies and are especially useful for 
modelling of intermolecular interactions [21]. Equation 3 may indicate that an 
intermolecular electron donor-acceptor interaction is involved in the enhancement 
process by hydrocarbons. 
In equation 4, log MW (logarithm of molecular weight) shows that smaller alcohol 
molecules with a higher number of double bonds are better penetration enhancers. X0 
in this equation is the difference between simple and valence corrected zero-order 
connectivity indices calculated by MOLCONN-Z software; therefore values of X0 
show the presence of heteroatoms or double (or triple) bonds. As all the alcohols 
under the study have only one heteroatom (oxygen), the higher X0 values in this 
series correspond to those molecules containing higher numbers of double bonds.  
Presence of q- in equation 5 and 6 indicates that a higher negative charge on the 
oxygen atoms of ethers and ketones increases the enhancement activities. 
 
[TABLE 4 HERE] 
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3.2. Enhancement activities of terpenes towards HC 
Stepwise regression analysis indicated that log P was the most significant descriptor 
of enhancement ratio of terpenes towards HC:  
 
Log ER = 0.719 (±0.09) + 0.153 (±0.03) log P (7) 
N = 12     s = 0.089     r2 = 0.760     F = 31.6   P = 0.000 
 
Comparing equations 7 and 2 reveals different structural requirements for terpenes to 
enhance penetration of hydrocortisone or 5FU; a high lipophilicity of terpenes will 
increase ER towards HC, while it will reduce ER towards 5FU. El-Kattan et al.. [12] 
suggested that the higher thermodynamic activity was responsible for the higher 
enhancement activity of hydrocarbon terpenes towards HC in the gel formulation.  
 
3.3. Enhancement activities of terpenes towards DFS 
Arellano and co-workers [13] investigated the enhancing effect of some terpenes on 
the in vitro percutaneous absorption of DFS from carbopol gels containing propylene 
glycol. The terpenes were from the chemical classes of hydrocarbons, alcohols, 
ketones and oxides. Unfortunately the thermodynamic activities of different terpenes 
were not equal as they were used at 1% w/w concentration in the gels. Assuming 
similar solubilities for the terpenes in the gel formulae, the enhancement ratio, which 
is the ratio of the kP value with enhancer to that obtained with control gel, was 
analysed.  
 
log ER = 0.297 (±0.18) + 0.017 (±0.006) ESP+ (8) 
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n = 8    s = 0.2977      r2 = 0.554     F = 7.4     P = 0.034 
ESP+ is the highest electrostatic potential on the solvent accessible surface of the 
molecules. This parameter describes the electrostatic intermolecular interactions 
(including hydrogen bonding) [19]. Therefore, equation 8 shows the positive effect of 
hydrogen bonding donor ability on the enhancement activity towards DFS. 
Correlation with log P is statistically insignificant (P = 0.17). 
 
3.4. Enhancement activities of terpenes towards ES 
Pretreatment of human epidermal membranes with terpenes results in a change in the 
permeability towards oestradiol [14]. Stepwise regression analysis of the enhancement 
ratios against the structural parameters of the enhancers resulted in the following 
QSAR: 
 
log ER = 0.743 (±0.30) - 0.206 (±0.03) S(I) - 2.91 (±1.5) q- (9) 
n = 12       s = 0.232          r2 = 0.853         F = 26.1    P = 0.000 
 
In equation 9, S(I) is the highest electrotopological state index in a molecule. 
Electrotopological indices encode information about both the topological environment 
of that atom and the electronic interactions due to all other atoms in the molecule; 
they may also be considered as measures of atomic electronic accessibility [22]. The 
ranking of different chemical classes of the terpenes with increasing S(I) values is 
hydrocarbons, ethers, alcohols and ketones. Hence increasing S(I) values correspond 
to the decreasing log ER values. In other words, hydrocarbons are the most potent 
enhancers and alcohols and ketones are the weakest. However, within the chemical 
classes, those with lower q- value have a higher activity. 
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Menthone is an outlier from this equation and its deletion improves the equation:  
log ER = 0.686 (±0.24) - 0.248 (±0.03) S(I) - 4.08(±1.33) q- (10) 
n = 11       s = 0.189          r2 = 0.906    F = 38.7   P = 0.000 
 
There is no correlation between the enhancement ratios and log P for this set (P = 
0.801). 
 
3.5. Enhancement activities of pyrrolidinone derivatives towards HC 
Stepwise regression analysis was performed for the enhancement ratios of 
permeability coefficient (kp, cm/h) and receptor concentration at 24 h (Q24, µM). This 
resulted in the following QSARs:  
 
Log ER (kp) = -0.281 (±0.11) + 1.23E-5 (±0.18E-5) (SA)2 (11) 
N = 16    r2 = 0.773     s = 0.30      F = 47.7    P = 0.000 
 
Log ER (Q24) = -0.083 (±0.06) + 0.84E-5 (±0.11E-5) (SA)2 (12) 
N = 16    r2 = 0.809     s = 0.18      F = 59.4    p = 0.000 
 
In equations 11 and 12, SA is accessible surface area of pyrrolidinone derivatives. 
The relationships of log ER(kp) and log ER(Q24) with SA2 indicates that larger 
pyrrolidinone derivatives are better enhancers of hydrocortisone penetration. Surface 
area is often correlated with the hydrophobicity of molecules, and in this 
pyrrolidinone series the correlation between SA2 and log P has an r2 value of 0.809. 
The correlation of log ER (kp) with log P was also explored and a weak positive 
correlation resulted: 
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Log ER (kp) = 0.114 (±0.10) + 0.172 (±0.04) log P (13) 
N = 16    r2 = 0.621     s = 0.38   F = 23.0    p = 0.000 
 
3.6. Enhancement activities of N-acetylprolinate esters towards HC 
Enhancement ratios for permeability coefficient (ER (kp)), diffusion coefficient (ER 
(D)) and membrane vehicle partition coefficient (ER (Km)) were analysed using 
stepwise regression analysis. The results showed that HDNAP (Figure 3) was an 
outlier from correlations. This could be due to the methods used for skin permeation 
studies using this enhancer. Unlike other enhancers, HDNAP was not soluble in 
propylene glycol, and therefore ethanol was used as a cosolvent [9]. Although a 
different control containing the same amount of ethanol was used for ER calculation, 
ethanol might have induced a synergistic effect with HDNAP. The synergy between 
ethanol and some other enhancers has been reported previously [23]. The following 
QSARs were obtained from stepwise regression analyses for the remainder of the 
enhancers: 
 
Log ER (kp) = - 1.76 (±1.23) + 1.21 (±0.48) log SA (14) 
n = 7     s = 0.101      r2 = 0.560     F = 6.4    P = 0.053 
 
Log ER (Km) = 1.31 (±0.19) - 0.103 (±0.035) log P (15) 
n = 7    s = 0.181      r2 = 0.629     F = 8.5   P = 0.033 
 
log ER (D) = - 0.19 (±0.16) + 0.158 (±0.03) log P (16) 
n = 7     s = 0.154      r2 = 0.845     F = 27.3   P = 0.003 
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The correlation between log ER (kp) and log P is: 
Log ER (kp) = 1.13 (±0.12) + 0.0452 (±0.02) log P (17) 
n = 7    s = 0.111      r2 = 0.461   F = 4.3      P = 0.093 
The positive coefficient of log P in equations 16 and 17, and the negative coefficient 
in equation 15, indicate that the positive relationship between enhancement of kP and 
log P of the enhancers is due to the increased ER of drug diffusion to the skin by 
enhancers with higher lipophilicity and not due to the increased partitioning. 
 
3.7. Enhancement activities of N-acetylprolinate esters towards benazepril 
For the reasons explained in section 3.5, HDNAP was an outlier in the QSARs and its 
exclusion resulted in the following QSARs from stepwise regression: 
Log ER (kp) = - 0.552 (±0.46) + 0.314 (±0.09) log P (18) 
n = 7   s = 0.438      r2 = 0.728     F = 13.4    P = 0.015 
 
Log ER (Km) = - 0.397 (±0.52) + 0.296 (±0.10) log P (19) 
n = 7     s = 0.493      r2 = 0.653     F = 9.4    P = 0.028 
The positive correlation between log ER (D) and log P was not statistically significant 
(P = 0.23) and is not presented here. The higher coefficient of log P in equation 18 
compared with that in equation 19 shows the effect of increased diffusion in higher 
lipophilicity enhancers. 
 
4. Discussion 
 
This study presents QSARs for enhancement ratios of skin penetration of penetrants 
by various chemical enhancers. The aim was to find the structural requirements of 
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chemicals in order to act as skin penetration enhancers of different drugs. Due to 
different procedures used for skin permeation studies, including the animal source of 
skin, the enhancer concentration, and the solvent, it was not possible to combine the 
ERs from different experiments. The enhancement ratios of terpenes towards 5FU 
depend mainly on the hydrogen bonding characteristic of the enhancers (equation 1). 
Moghimi et al. [11] suggested that terpenes might increase the permeation of 5-
fluorouracil through the stratum corneum as a result of a molecular complex 
formation between the drug and the enhancer. The equation shows that an electron 
donor-acceptor interaction could be involved in the facilitated transport, which may or 
may not be between the drug and the enhancer. Likewise, the QSARs obtained for 
different chemical classes of terpenes (Table 4, equations 3-6) involve descriptors 
indicative of possible intermolecular interactions: In equation 3 the nucleophilic 
superdelocalisability index of double bonding carbon atoms could be an indicator of 
charge transfer interactions. Equation 4 shows that a higher number of double bonds 
(indicated by a high X0) in smaller (low molecular weight) alcohol molecules have a 
higher enhancing potency. Moreover, equations 5 and 6 involve correlation of ER 
with the most negative atomic charge, which is often an indicator of hydrogen 
bonding acceptor ability [19]. 
Hydrophobicity has a negative effect on the enhancement activity of terpenes towards 
5FU (equation 2). This is in contrast with the positive correlation observed between 
log P and ER of terpenes, pyrrolidinones, and N-acetylprolinates, towards HC 
(equations 7, 13 and 17, respectively), and ER of N-acetylprolinates towards 
benazepril (equation 18). This is also in contrast with previous findings that suggest a 
positive or parabolic correlation between hydrophobicity and ER. Among these are 
the study of Aungst et al. [24] indicating a parabolic effect of alkyl chain lengths of 
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enhancers of naloxone penetration through human skin in vitro, and the parabolic 
relationship observed between the enhancement ratio of ketoprofen percutaneous 
absorption and octanol/water partition coefficient of cyclohexanol derivatives as the 
enhancers [25]. However, a number of studies indicate that the enhancing effect of an 
enhancer depends on actual the permeation pathway of the drug [26, 4, 27]. 
Accordingly, the activity of an enhancer is related to the structure of the drug as well 
as that of the enhancer. There are several suggested mechanisms (action sites) 
involved in the penetration enhancement activities of various enhancers. These have 
been summarised by Barry [28, 29] as the lipid-protein-partitioning theory. According 
to this theory, accelerants may act by one or more of the three main mechanisms. 
They may alter the lipid domain of the stratum corneum, may interact with the protein 
components, or may increase partitioning of the model drug or the coadministered 
vehicles, or of water into the skin. The alteration of the lipid domain occurs by 
fluidisation of the stratum corneum lipids. Figure 5 shows the chemical structures and 
some properties of the penetrants used in this study. It can be seen that 5FU is much 
more hydrophobic than are HC and benazepril. Therefore, the different structural 
characteristics of enhancers required for the promotion of 5FU, HC and benazepril 
transport might be due to a different mechanism by which the drug moves across the 
SC. Another explanation could be the molecular complex formation between 5FU and 
the terpenes as suggested by Moghimi et al. [11]. 
 
[FIGURE 5 HERE] 
 
For estradiol, although there was no statistically significant correlation between log 
ER and log P, equation 9 shows that hydrophilic alcohols and ketones are weak and 
 17 
hydrophobic hydrocarbons strong penetration enhancers. Considering the high 
hydrophobicity of estradiol (log D = 4.13), this follows the argument made earlier. 
Enhancement of DFS penetration, on the other hand, shows a positive relationship 
with the maximum electrostatic potential on the surface of the terpene enhancers 
(equation 8), suggesting a higher activity for the alcohols in comparison with ethers, 
ketones and hydrocarbons. Furthermore, there is no significant correlation with log P. 
It can be seen in Figure 5 that log D for DFS is lower than that for estradiol, but, it is 
slightly higher than that for benazepril. Considering, for the latter drug, the positive 
relationship of enhancement activities of N-acetylprolinate esters with 
hydrophobicity, a similar correlation is expected for the enhancers of the more 
hydrophobic DFS. However, it should be noted that the type of enhancers, the animal 
speices used for the penetration study and the experimental procedures (concentration, 
solvent, etc) are different for the two series of enhancers. Moreover, the pKa value 
used for the calculation of log D at pH 7.4 is experimentally measured for DFS but is 
estimated for benazepril. Therefore, it may be that the acidity has been overestimated, 
leading to an underestimated log D for benazepril. 
A final note that is worth stressing is that the skin types used for some of the 
penetration studies are not human skin: In the study of the effect of tepenes on DFS 
penetration abdominal rat skin has been used; for the studies on the effects of terpenes 
on the penetration of HC, as well as pyrrolidinone derivatives and N-acetyl prolinate 
esters the barrier used is hairless mouse skin. Therefore the results of QSAR analyses 
for penetration enhancement through human skin might be different. 
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Conclusion 
Structural requirements for penetration enhancement of several penetrants with 
varying lipophilicities by three groups of enhancers were studied using QSAR 
technique. The resulting QSARs for enhancement towards different drugs 
incorporated different structural descriptors suggesting involvement of different 
mechanisms. For 5-fluorouracil and diclofenac sodium molecular descriptors in the 
corresponding QSARs indicated the possible involvement of intermolecular electron 
donor-acceptor interactions. Effect of log P of enhancers on the enhancement ratio 
was contradictory for different drugs. It ranged from a negative effect for 5-
fluorouracil to a positive effect for hydrocortisone. The QSARs could shed some light 
on the mechanism of drug penetration. 
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Table 1. Penetration enhancement activities of terpenes towards 5-fluorouracil (5FU), 
hydrocortisone (HC), diclofenac sodium (DFS) and oestradiol (ES) 
No. Terpene ER 
5FU a HC b DFS c ES d 
1 (+)-b-Cedrene 2.7 - - - 
2 (-)-trans-Caryophyllene 2.0 - - - 
3 1R-(+)-a-Pinene 1.2 28.4 - 3.09 
4 (+)-Limonene 2.1 - 3.53 3.75 
5 (+)-Longifolene 1.7 - - - 
6 (-)-Guaiol 3.8 - - - 
7 (+)-Aromadendrene 2.5 - - - 
8 Safrole 5.0 - - - 
9 (+)-Cedrol 4.6 13.1 - - 
10 R-(-)-Carvone 12.0 - - 0.10 
11 (+)-Limonene oxide 11.0 - - 1.61 
12 Cyclopentene oxide 31.0 18.7 - - 
13 (-)-Menthone 38.0 - 3.07 0.36 
14 Cyclohexene oxide 2.4 - - 1.42 
15 (-)-a-Pinene oxide 14.0 10.1 - 1.90 
16 1R-(-)-Fenchone 7.8 14.5 1.87 - 
17 1,8-Cineole 94.0 - 1.39 4.40 
18 7-Oxabicyclo [2.2.1] heptane 92.0 - - 4.93 
19 Phytol 3.4 - - - 
20 Farnesol 14.0 35.3 - - 
21 Nerolidol 23.0 - 13.60 - 
22 (-)-Carveol 20.0 - - 0.42 
23 (-)-a-Bisabolol 8.4 16.9 - - 
24 Geraniol 18.0 13.3 18.97 - 
25 a-Terpineol 9.4 11.3 - 0.33 
26 (+)-Terpinen-4-ol 10.0 - - 0.45 
27 Verbenone - 11.5 - - 
28 Thymol - 11.0 4.74 - 
29 Cymene - -22.9 - - 
30 Menthol - - 10.63 - 
31 3-Carene - - - 4.36 
32 Pulegone - - - 0.34 
33 Piperitone - - - 0.17 
34 Ascaridole - - - 4.75 
a data taken from Moghimi et al. [11];  b data taken from El-Kattan et al. [12];  c data 
taken from Arellano et al. [13]; d data taken from Williams and Barry [14]. 
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Table 2. Penetration enhancement activities of pyrrolidinone derivatives 
No. ER (kp) ER (Q24) 
1 5.4 5.2 
2 42.0 23.0 
3 0.6 1.2 
4 0.9 1.0 
5 1.2 1.1 
6 0.8 1.3 
7 1.4 1.3 
8 3.9 1.4 
9 0.8 1.2 
10 0.4 1.8 
11 0.7 1.1 
12 1.4 1.4 
13 41.0 11.0 
14 0.9 1.1 
15 1.0 1.2 
16 1.9 2.0 
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Table 3. Penetration enhancement activities of N-acetylprolinate esters 
Compound Hydrocortisone Benazepril 
ER (kp) ER (Km) ER (D) ER (kp) ER (Km) ER (D) 
PNAP 14.4 7.65 1.94 1.2 1.56 0.92 
ONAP 17.7 14.96 1.24 1.0 1.06 0.91 
DNAP 18.2 6.60 2.86 4.5 5.44 0.80 
UNAP 30.6 6.70 4.89 40.1 53.75 0.70 
DDNAP 34.3 8.46 4.41 23.7 28.63 0.78 
HDNAP 13.8 4.07 1.80 6.1 3.02 1.98 
Oleyl-NAP 27.1 2.14 14.79 40.6 35.25 1.11 
Azone 22.0 3.68 6.90 67.7 82.44 0.79 
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Table 4. QSARs obtained for different chemical classes of terpenes 
No. Chemical 
group 
Equation n r2 s F P 
3 Hydrocarbons Log ER = 31.8 (±8.37) - 120 (±31.8) 
S=N 
6 0.780 0.067 14.2 0.02 
4 Alcohols Log ER = 3.77 (±0.55) - 1.59 (±0.23) 
log MW + 0.931 (±0.09) X0 
10 0.958 0.070 79.0 0.00 
5 Ethers Log ER = - 3.72 (±1.9) – 18.2 (±7.1) q- 7 0.566 0.438 6.5 0.05 
6 Ethers & 
ketones 
Log ER = - 3.58 (±1.7) - 17.4 (±6.2) q- 10 0.496 0.394 7.8 0.02 
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Figure 1. Chemical structures of terpenes. 
 
 
 
CH3
CH3
CH2
CH3
H
H
CH2
CH3
CH3 CH3H
H
CH3
CH3
CH3 CH2CH3
CH3
CH2
CH3
CH3CH3
OH
CH3 CH3
CH3
CH3
CH3
CH3 CH3
CH2
H
H
HH
OO
CH2
CH3
CH3
CH3
CH3
OH
H
O
CH2
CH3
CH3
H
CH2CH3
CH3 O
O
CH3 CH3
CH3
O O
CH3
CH3CH3
O
CH3 CH3
CH3
O
O
CH3
CH3
CH3
O
OH
CH3
CH3
CH3
CH3CH3 HH OHCH3
CH3 CH3 CH3
CH2
OH
CH3
CH3
CH3
CH3
CH2
OH
CH3
CH3
CH3
CH3
OH
CH3
CH3
OH
CH3
CH3
CH3
OHCH3
CH3
CH3
CH3
CH3
CH3
OH
CH3
CH3
CH3
O
CH3 CH3
CH3
OH
Verbenone
Thymol
CH3 CH3
CH3
CH3 CH3
OH
CH3
Cymene Menthol
(+)-b-Cedrene (-)-trans-Caryophyllene 1R-(+)-a-Pinene (+)-Limonene (+)-Longifolene (-)-Guaiol
(+)-Aromadendrene
Safrole
(+)-Cedrole
R-(-)-Carvone
(+)-Limonene 
oxide
Cyclopentene 
oxide
(-)-a-Pinene 
oxide(-)-Menthone
Cyclohexene 
oxide
1R-(-)-Fenchone 1,8-Cineole 7-Oxabicyclo [2.2.1] heptane
Phytol Farnesol Nerolidol
(-)-Carveol (-)-a-Bisabolol
Geraniol
a-Terpineol (+)-Terpinen-4-ol
CH3
CH3
CH3
O
CH3CH3
CH3
O
CH3
CH3 CH3
O
O
CH3
CH3CH3
3-Carene
Pulegone Piperitone Ascaridole
 27 
O
N
(CH2)11CH3N
(CH2)11CH3 NH
O
N
O
CH3
N
O
C2H5
NH
O
CH3
N
O
CH3
CH3
N
O
CH3
O
N
O
(CH2)5CH3 NH
O
CH3
NH
O
COOH
N CH3
N
O
CH2 C
O
O (CH2)11CH3 NH
O
C
O
O C2H5
N
O
N
H
OCH3
H3CO
N-dodecyl-pyrrolidine N-dodecy-2-pyrrolidinone 2-pyrrolidinone 1-methyl-2-pyrrolidinone
1-ethyl-2-pyrrolidinone 5-methyl-2-pyrrolidinone 1,5-dimethyl-2-pyrrolidinone
1-methylsuccinimide
1-hexyl-2-pyrrolidinone 3-methyl-2-pyrrolidinone
2-pyrrolidinone-5-carboxylic acid 1-methylpyrrolidine
2-pyrrolidinone-1-acetic acid 
dodecyl ester ethyl-2-pyrrolidinone-5-carboxylate
1-cyclohexyl-2-pyrrolidinone 2,5-bis(methoxymethyl)
pyrrolidine
Figure 2. Chemical structures of pyrrolidinone derivatives. 
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N
O
CH3
COOR
N-Acetylprolinate
(Compounds 1-7)
 
No. Compound R 
1 n-Pentyl-N-acetylprolinate (PNAP) -C5H11 
2 n-Octyl-N-acetylprolinate (ONAP) -C8H17 
3 n-Decyl-N-acetylprolinate (DNAP -C10H21 
4 n-Undecyl-N-acetylprolinate (UNAP) -C11H23 
5 n-Dodecyl-N-acetylprolinate (DDNAP -C12H25 
6 n-Hexadecyl-N-acetylprolinate (HDNAP) -C16H33 
7 9-Octadecenyl-N-acetylprolinate (Oleyl-NAP) -C18H35 
 
 
  
 
Figure 3. Chemical structures of N-acetylprolinate esters and Azone. 
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Figure 4. Scatter plot between observed log ER and the log ER calculated using 
equation 1. 
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Figure 5. Chemical structures of drugs (penetrants) together with some of the 
physicochemical properties calculated by ACD/log D Suite. 
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